About John Rea
Form D filings for RxCap in 2024 list John Rea as director.
John Rea first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name John Rea in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people John Rea works with at each company, as listed on that company's latest Form D.
RxCap, Inc. · Form D/A, May 8, 2024
TH
Toby Haba
Director
WS
Will Shrank
Director
MF
Mike Furlotti
Director
SR
Sreeram Ramakrishnan
President and director